Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend.

By Editor Last updated Jun 21, 2021

Prev Post

Former PM Manmohan Singh to chair a meeting of Congress committee on J&K affairs, via video conference tomorrow; Ghulam Nabi Azad, Karan Singh, P Chidambaram & party’s J&K chief Ghulam Ahmad Mir to participate

Next Post

35 cases of new Delta-plus variant in India, 21 in Maharashtra